// App-Quantinova.ai

2754 : Upfront Alternative Donor Transplant Versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack Fully HLA Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies. on Behalf of the Severe Aplastic Anemia Working Party of European Group for Blood and Marrow Transplantation (SAAWP of EBMT)

Researchers

Presenter

  • Hind Alotaibi

Principal Investigators

  • Regis Peffault De Latour

  • Shahid Iqbal

  • Andrea Bacigalupo

  • Judith Marsh

  • Hubert Schrezenmeier

  • Eliane Gluckman

  • Mansour Alfayez

  • Britta Hoechsmann

  • Constantijn Halkes

  • Josu de la Fuente

  • Nawal AlShehry

  • Simone Cesaro

  • Jakob Passweg

  • Carlo Dufour

  • Antonio Risitano

  • John F. DiPersio

  • Ibraheem Motabi

Medical Centers

  • King Abdulaziz Medical City, Riyadh, Saudi Arabia

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

  • Aphp Saint-Louis Hospital, Paris, France

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • Universita Cattolica del Sacro Cuore, Rome, Italy

  • King’s College Hospital/Kings College London United Kingdom

  • University of Ulm, Ulm, Germany

  • Hôpital Saint-Louis, Assitance Publique – Hôpitaux de Paris, Université de Paris, Inserm,Paris,France

  • Monacord, Centre Scientifique de Monaco, Principauté de Monaco, Monaco, France

  • Leiden University Medical Centre, Leiden, Netherlands

  • Imperial College Healthcare NHS Trust & Imperial College London, London, United Kingdom

  • Paediatric Haematology Oncology,Azienda Ospedaliera Universitaria Integrata,Verona,Italie

  • University Hospital Basel, Basel, Switzerland

  • Hematology-Oncology Department, G. Gaslini Children Hospital, Genova, Italy

  • Hematology and BMT Unit, Moscati Hospital, Avellino, Italy

  • Washington University School of Medicine, St. Louis, MO

Locations

  • Saudi Arabia

  • France

  • United Kingdom

  • Italy

  • Germany

  • Netherlands

  • Switzerland

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Aplastic anemia

Biomarkers

  • Serum amyloid A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A